HALOZYME THERAPEUTICS, INC. Operating Cash Flow
HALOZYME THERAPEUTICS, INC. (HALO) reported Operating Cash Flow of $420.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $240.89M, a 141.59% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $180.08M, a 16.77% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $219.03M, a 22.73% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $178.60M, a 54.80% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $651.56M, a 36.01% increase from fiscal 2024.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $479.06M, a 23.29% increase from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was $388.57M, a 61.83% increase from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $240.11M, a 19.81% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $240.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $420.97M 10-Q · filed 2026-08-06 | $640.00M derived: sum of 3 quarters · filed 2026-08-06 | $818.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $180.08M 10-Q · filed 2026-05-11 | $399.11M derived: sum of 2 quarters · filed 2026-05-11 | $577.70M derived: sum of 3 quarters · filed 2026-05-11 | $677.41M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $219.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $397.63M derived: sum of 2 quarters · filed 2026-02-17 | $497.34M derived: sum of 3 quarters · filed 2026-08-06 | $651.56M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $178.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $278.31M derived: sum of 2 quarters · filed 2026-08-06 | $432.53M 10-Q · filed 2025-11-03 | $611.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $99.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $253.93M 10-Q · filed 2026-08-06 | $432.40M derived: sum of 3 quarters · filed 2026-08-06 | $547.77M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $154.22M 10-Q · filed 2026-05-11 | $332.69M derived: sum of 2 quarters · filed 2026-05-11 | $448.06M derived: sum of 3 quarters · filed 2026-05-11 | $503.86M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $178.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $293.84M derived: sum of 2 quarters · filed 2026-02-17 | $349.64M derived: sum of 3 quarters · filed 2026-02-17 | $479.06M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $115.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $171.17M derived: sum of 2 quarters · filed 2025-11-03 | $300.60M 10-Q · filed 2025-11-03 | $402.95M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $55.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $185.22M 10-Q · filed 2025-08-05 | $287.57M derived: sum of 3 quarters · filed 2026-02-17 | $419.99M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $129.43M 10-Q · filed 2025-05-06 | $231.78M derived: sum of 2 quarters · filed 2026-02-17 | $364.19M derived: sum of 3 quarters · filed 2026-02-17 | $431.03M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $102.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $234.76M derived: sum of 2 quarters · filed 2026-02-17 | $301.61M derived: sum of 3 quarters · filed 2026-02-17 | $388.57M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $132.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $199.25M derived: sum of 2 quarters · filed 2024-10-31 | $286.22M 10-Q · filed 2024-10-31 | $368.67M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $66.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $153.81M 10-Q · filed 2024-08-06 | $236.26M derived: sum of 3 quarters · filed 2025-02-18 | $305.89M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $86.96M 10-Q · filed 2024-05-07 | $169.42M derived: sum of 2 quarters · filed 2025-02-18 | $239.05M derived: sum of 3 quarters · filed 2025-02-18 | $279.28M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $82.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $152.09M derived: sum of 2 quarters · filed 2025-02-18 | $192.31M derived: sum of 3 quarters · filed 2025-02-18 | $240.11M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $69.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $109.86M derived: sum of 2 quarters · filed 2023-11-06 | $157.66M 10-Q · filed 2023-11-06 | $240.17M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $40.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $88.02M 10-Q · filed 2023-08-08 | $170.54M derived: sum of 3 quarters · filed 2024-02-20 | $292.28M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $47.80M 10-Q · filed 2023-05-09 | $130.31M derived: sum of 2 quarters · filed 2024-02-20 | $252.05M derived: sum of 3 quarters · filed 2024-02-20 | $288.94M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $82.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $204.25M derived: sum of 2 quarters · filed 2024-02-20 | $241.14M derived: sum of 3 quarters · filed 2024-02-20 | $299.44M 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $121.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $158.63M derived: sum of 2 quarters · filed 2022-11-08 | $216.92M 10-Q · filed 2022-11-08 | $267.84M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $36.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $95.19M 10-Q · filed 2022-08-09 | $146.10M derived: sum of 3 quarters · filed 2023-02-21 | $152.19M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $58.30M 10-Q · filed 2022-05-10 | $109.22M derived: sum of 2 quarters · filed 2023-02-21 | $115.30M derived: sum of 3 quarters · filed 2023-02-21 | $118.59M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $50.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $57.00M derived: sum of 2 quarters · filed 2023-02-21 | $60.30M derived: sum of 3 quarters · filed 2023-02-21 | $55.45M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $9.38M derived: sum of 2 quarters · filed 2021-11-02 | $4.53M 10-Q · filed 2021-11-02 | -$22.09M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.55M 10-Q · filed 2021-08-09 | -$28.18M derived: sum of 3 quarters · filed 2022-02-22 | -$57.76M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | -$4.84M 10-Q · filed 2021-05-10 | -$31.47M derived: sum of 2 quarters · filed 2022-02-22 | -$61.06M derived: sum of 3 quarters · filed 2022-02-22 | -$85.84M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | -$26.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$56.21M derived: sum of 2 quarters · filed 2022-02-22 | -$81.00M derived: sum of 3 quarters · filed 2022-02-22 | -$85.42M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | -$29.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$54.37M derived: sum of 2 quarters · filed 2020-11-02 | -$58.80M 10-Q · filed 2020-11-02 | -$48.34M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | -$24.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$29.21M 10-Q · filed 2020-08-10 | -$18.75M derived: sum of 3 quarters · filed 2021-02-23 | -$37.67M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | -$4.42M 10-Q · filed 2020-05-11 | $6.04M derived: sum of 2 quarters · filed 2021-02-23 | -$12.89M derived: sum of 3 quarters · filed 2021-02-23 | -$31.75M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$8.46M derived: sum of 2 quarters · filed 2021-02-23 | -$27.32M derived: sum of 3 quarters · filed 2021-02-23 | -$49.50M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | -$18.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$37.78M derived: sum of 2 quarters · filed 2019-11-12 | -$59.96M 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$18.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$41.03M 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | -$22.18M 10-Q · filed 2019-05-07 | |||||||
| 2017-12-31 | $134.05M 10-K · filed 2020-02-24 | |||||||
| 2016-12-31 | -$50.38M 10-K · filed 2017-02-28 | |||||||
| 2015-12-31 | -$37.08M 10-K · filed 2017-02-28 | |||||||
| 2015-06-30 | $8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$4.90M 10-Q · filed 2015-08-10 | -$5.84M derived: sum of 3 quarters · filed 2017-02-28 | -$19.02M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$13.84M 10-Q · filed 2015-05-11 | -$14.78M derived: sum of 2 quarters · filed 2017-02-28 | -$27.96M derived: sum of 3 quarters · filed 2017-02-28 | -$43.73M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$939.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$14.12M derived: sum of 2 quarters · filed 2017-02-28 | -$29.89M derived: sum of 3 quarters · filed 2017-02-28 | -$47.52M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | -$13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$28.95M derived: sum of 2 quarters · filed 2015-08-10 | -$46.58M 10-Q · filed 2014-11-10 | -$61.80M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$33.40M 10-Q · filed 2015-08-10 | -$48.62M derived: sum of 3 quarters · filed 2016-02-29 | -$61.03M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$17.63M 10-Q · filed 2015-05-11 | -$32.85M derived: sum of 2 quarters · filed 2016-02-29 | -$45.26M derived: sum of 3 quarters · filed 2016-02-29 | -$56.22M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$15.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$27.63M derived: sum of 2 quarters · filed 2016-02-29 | -$38.59M derived: sum of 3 quarters · filed 2016-02-29 | -$49.34M 10-K · filed 2016-02-29 | -$49.34M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$12.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$23.37M derived: sum of 2 quarters · filed 2014-11-10 | -$34.12M 10-Q · filed 2014-11-10 | -$34.12M 10-Q · filed 2013-11-08 | -$50.99M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | -$10.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$21.70M 10-Q · filed 2014-08-11 | -$21.71M 10-Q · filed 2013-08-07 | -$38.57M derived: sum of 3 quarters · filed 2015-03-02 | -$52.87M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | -$10.75M 10-Q · filed 2014-05-12 | -$10.75M 10-Q · filed 2013-05-08 | -$27.62M derived: sum of 2 quarters · filed 2015-03-02 | -$41.92M derived: sum of 3 quarters · filed 2015-03-02 | -$55.67M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$16.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$31.17M derived: sum of 2 quarters · filed 2015-03-02 | -$44.92M derived: sum of 3 quarters · filed 2015-03-02 | -$64.28M 10-K · filed 2015-03-02 | -$64.33M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$14.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$28.05M derived: sum of 2 quarters · filed 2013-11-08 | -$47.41M 10-Q · filed 2013-11-08 | -$60.91M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$13.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$33.11M 10-Q · filed 2013-08-07 | -$46.62M derived: sum of 3 quarters · filed 2014-02-28 | -$60.06M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | -$19.36M 10-Q · filed 2013-05-08 | -$32.86M derived: sum of 2 quarters · filed 2014-02-28 | -$46.30M derived: sum of 3 quarters · filed 2014-02-28 | -$42.57M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$26.95M derived: sum of 2 quarters · filed 2014-02-28 | -$23.21M derived: sum of 3 quarters · filed 2014-02-28 | -$34.30M 10-K · filed 2014-02-28 | -$34.35M 10-K · filed 2012-03-12 | |||
| 2011-09-30 | -$13.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$9.70M derived: sum of 2 quarters · filed 2012-11-08 | -$20.80M 10-Q · filed 2012-11-08 | -$28.17M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$7.35M 10-Q · filed 2012-08-09 | -$14.73M derived: sum of 3 quarters · filed 2013-03-01 | -$26.34M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$11.09M 10-Q · filed 2012-05-07 | -$18.47M derived: sum of 2 quarters · filed 2013-03-01 | -$30.08M derived: sum of 3 quarters · filed 2013-03-01 | |||||
| 2010-12-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$18.99M derived: sum of 2 quarters · filed 2013-03-01 | -$45.39M 10-K · filed 2013-03-01 | |||||
| 2010-09-30 | -$11.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$38.01M 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | -$26.39M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$40.15M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |